Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis

BACKGROUND: Autoimmune disorders including nephropathies have been reported more frequently in alemtuzumab-treated multiple sclerosis (MS) patients than in the general population. OBJECTIVE: Describe instances of autoimmune nephropathy in alemtuzumab-treated MS patients. METHODS: Cases were identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelps, Richard, Winston, Jonathan A, Wynn, Daniel, Habek, Mario, Hartung, Hans-Peter, Havrdová, Eva Kubala, Markowitz, Glen S, Margolin, David H, Rodriguez, Claudio E, Baker, Darren P, Coles, Alasdair J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681440/
https://www.ncbi.nlm.nih.gov/pubmed/30986126
http://dx.doi.org/10.1177/1352458519841829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681440/
https://www.ncbi.nlm.nih.gov/pubmed/30986126
http://dx.doi.org/10.1177/1352458519841829

Ejemplares similares